Jeanmarie Mayer, M.D.

Bio

Jeanmarie Mayer, MD, is the Hospital Epidemiologist for the University of Utah Health Care Hospitals and Clinics. As a Healthcare Epidemiologist and an Infectious Disease specialist, her clinical interests focus on the prevention of healthcare-associated infections. She deals with all aspects of the healthcare setting to reduce the transmission of multidrug resistant organisms and prevent patients or staff from acquiring a healthcare-associated infection through surveillance, conducting outbreak investigations, development of policies, audits, teaching, providing advice and consultation, and leading quality improvement initiatives.

Dr. Mayer received her Bachelor of Science Degree from William Smith College. She received training in medicine from the University of Rochester School of Medicine and Dentistry. In the past, Dr. Mayer served as Chair of the Utah Healthcare Associated Infection Work Group and she currently has a state leadership role as Chair of the Utah Healthcare Infection Prevention Governance Committee. She is a member of the Society for Healthcare Epidemiology of America, and serves on this organization's Guidelines Writing Committee as well as their Expert Antimicrobial Utilization Consultation Panel.

Board Certification and Academic Information

Board Certification and Academic Information

Academic Office Locations

Academic Bio

Jeanmarie Mayer, MD, is the Hospital Epidemiologist for the University of Utah Health Care Hospitals and Clinics and has a leadership role in the state as Chair of the Utah Healthcare Infection Prevention Governance Committee. As a Healthcare Epidemiologist and an Infectious Disease specialist, her research interests include developing and evaluating surveillance systems for healthcare associated infections, studying the transmission of and risk factors for Clostridium difficile infection in both acute care and long term care facilities, and in systems redesign to improve processes to prevent healthcare associated infections.

Dr. Mayer participated in the CDC Prevention Epicenter Program which led to several articles in peer reviewed journals, from a project she led in evaluating inter-rater reliability in identifying nosocomial infections as well as partaking in a multicenter study for surveillance of Clostridium difficile. Her work studying the transmission and epidemiology of Clostridium difficile infection continues within the VA Prevention Epicenter Program. She has also successfully led a CDC funded project with Information Technology and Pharmacy at the University of Utah on Building Epidemiology, Laboratory, and Health Information Systems Capacity through Antimicrobial Use Surveillance.

Dr. Mayer is particularly interested in local projects focused on behavior and culture change to improve patient safety. She is actively participating in a comprehensive unit-based safety program with other healthcare professionals at the University of Utah. Dr. Mayer is collaborating with University of Utah Human Factors Experts from the Department of Psychology in redesigning equipment to increase adherence to best practices with central line maintenance. She has published a major article on a hospital-wide multimodal intervention that led to sustained improvement in healthcare worker hand hygiene practices and is currently developing effective tools to facilitate front line staff investigation of healthcare associated infections.

Education History

Selected Provider Publications

Journal Article

1. Donskey CJ, Sunkesula VC, Jencson AL, Stone ND, Gould CV, McDonald LC, Samore M, Mayer J, Pacheco S, Sambol S, Petrella L, Terry D, Gerding DN (2014). Utility of a commercial PCR assay and a clinical prediction rule for detection of toxigenic Clostridium difficile in asymptomatic carriers. J Clin Microbiol, 52(1), 315-8.
2. Bearman G, Bryant K, Leekha S, Mayer J, Munoz-Price LS, Murthy R, Palmore T, Rupp ME, White J (2014). Healthcare personnel attire in non-operating-room settings. Infect Control Hosp Epidemiol, 35(2), 107-21.
3. Donskey CJ, Sunkesula VC, Jencson AL, Stone ND, Gould CV, McDonald LC, Samore M, Mayer J, Pacheco S, Sambol S, Petrella L, Terry D, Gerding DN (2013). Utility of a Commercial Polymerase Chain Reaction Assay and a Clinical Prediction Rule for Detection of Asymptomatic Carriers of Toxigenic Clostridium difficile. J Clin Microbiol.
4. Mayer J, Greene T, Howell J, Ying J, Rubin MA, Trick WE, Samore MH (2012). Agreement in classifying bloodstream infections among multiple reviewers conducting surveillance. Clin Infect Dis, 55(3), 364-70.
5. de Perio MA, Brueck SE, Mueller CA, Milne CK, Rubin MA, Gundlapalli AV, Mayer J (2012). Evaluation of 2009 pandemic influenza A (H1N1) exposures and illness among physicians in training. Am J Infect Control, 40(7), 617-21.

Review

1. Staes C, Jacobs J, Mayer J, Allen J (2013). Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12. [Review]. Am J Health Syst Pharm, 70(15), 1301-12.

News

• Concerns About ERCP Scopes
• Measles Infects More Than 100 People, Including Some in Utah

Video